Shane Barton

CIK: 0001836297

Transaction Breakdown

Open Market Buys (P)1 (7.1%)

High conviction signal

Open Market Sales (S)2 (14.3%)

Position reduction

Option Exercises (M)8 (57.1%)

Derivative conversions

Awards (A)3 (21.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIOA

BioAge Labs, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

BIOA
BioAge Labs, Inc.
Jun 30, 2026
Exercise(M)
Direct
4.3K shares at avg. $10.85$47K
BIOA
BioAge Labs, Inc.
Jun 30, 2026
Exercise(M)
Direct
4K shares at avg. $8.39$34K
BIOA
BioAge Labs, Inc.
Jun 30, 2026
Exercise(M)
Direct
4.1K shares at avg. $4.30$17K
BIOA
BioAge Labs, Inc.
Jun 30, 2026
Exercise(M)
Direct
7.9K shares at avg. $4.38$34K
BIOA
BioAge Labs, Inc.
Jun 30, 2026
Sale(S)
Direct
20.2K shares at avg. $25.19$509K
BIOA
BioAge Labs, Inc.
Jun 29, 2026
Exercise(M)
Direct
9.3K shares at avg. $10.85$101K
BIOA
BioAge Labs, Inc.
Jun 29, 2026
Exercise(M)
Direct
7.3K shares at avg. $8.39$61K
BIOA
BioAge Labs, Inc.
Jun 29, 2026
Exercise(M)
Direct
9K shares at avg. $4.30$39K
BIOA
BioAge Labs, Inc.
Jun 29, 2026
Exercise(M)
Direct
14.2K shares at avg. $4.38$62K
BIOA
BioAge Labs, Inc.
Jun 29, 2026
Sale(S)
Direct
42.4K shares at avg. $25.21$1.1M
BIOA
BioAge Labs, Inc.
Feb 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
45K shares-
BIOA
BioAge Labs, Inc.
Feb 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
90K shares-
BIOA
BioAge Labs, Inc.
Dec 18, 2024
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-
BIOA
BioAge Labs, Inc.
Sep 27, 2024
Purchase(P)
Direct
2.6K shares at avg. $18.00$47K

		Type	Shares	Price		Ownership
Jun 30, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	4,290	$10.85	$46,547	Direct
Jun 30, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	4,000	$8.39	$33,560	Direct
Jun 30, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	4,065	$4.30	$17,480	Direct
Jun 30, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	7,861	$4.38	$34,431	Direct
Jun 30, 2026	BIOA BioAge Labs, Inc.	Sale(S)	20,216	$25.19	$509,176	Direct
Jun 29, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	9,301	$10.85	$100,916	Direct
Jun 29, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	7,261	$8.39	$60,920	Direct
Jun 29, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	8,958	$4.30	$38,519	Direct
Jun 29, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	14,198	$4.38	$62,187	Direct
Jun 29, 2026	BIOA BioAge Labs, Inc.	Sale(S)	42,350	$25.21	$1,067,576	Direct
Feb 17, 2026	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	45,000	-	-	Direct
Feb 18, 2025	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	90,000	-	-	Direct
Dec 18, 2024	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct
Sep 27, 2024	BIOA BioAge Labs, Inc.	Purchase(P)	2,632	$18.00	$47,376	Direct

1-14 of 14 transactions

About Barton Shane

Barton Shane (SEC CIK 0001836297) files insider reports with the SEC as Principal Accounting Officer of BioAge Labs, Inc. (BIOA).

Signal8 holds 6 ownership filings by Barton Shane (1 Form 3, 5 Form 4), filed between Sep 25, 2024 and Jul 1, 2026. Those filings report 14 transactions, from Sep 27, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Barton Shane's filings is in EMERYVILLE, CA.

Recent filings by Barton Shane

Jun 30, 2026: Option exercises of BIOA shares (4 lines, Form 4, code M).
Jun 30, 2026: Open-market sale of BIOA shares (Form 4, code S).
Jun 29, 2026: Option exercises of BIOA shares (4 lines, Form 4, code M).
Jun 29, 2026: Open-market sale of BIOA shares (Form 4, code S).
Feb 17, 2026: Grant or award of BIOA derivative securities (Form 4, code A).

Other insiders filing for BioAge Labs, Inc. (BIOA)

How to read Form 4 transaction codes